Confidence and uncertainty long after initial treatment for early prostate cancer: Survivors' views of cancer control and the treatment decisions they made

Journal of Clinical Oncology

Volumn 24, Issue 27, 2006, Pages 4457-4463

  Clark, Jack A ^a   Talcott, James A ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER SURVIVAL; CONTROLLED STUDY; DECISION MAKING; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF ESTEEM; SEXUAL DYSFUNCTION; URINARY DYSFUNCTION; BLOOD; CANCER STAGING; FOLLOW UP; IMMUNOLOGY; IMPOTENCE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE TUMOR; RISK FACTOR; STATISTICAL MODEL; UNCERTAINTY;

AGED; AGED, 80 AND OVER; CHOICE BEHAVIOR; DECISION MAKING; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UNCERTAINTY;

EID: 33749049973     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.2893     Document Type: Article

References (26)

1. Maliski S, Heilemann M, McCorkle R: From 'death sentence' to 'good cancer': Couples' transformation of a prostate cancer diagnosis. Nurs Res 51:391-397, 2002
2. O'Rourke M: Narrowing the options: The process of deciding on prostate cancer treatment. Cancer Invest 17:349-359, 1999
3. Kunkle E, Myers R, Lartey P, et al: Communicating effectively with the patient and family about treatment options for prostate cancer. Semin Urol Oncol 18:233-240, 2000
4. Holmboe E, Concato J: Treatment decisions for localized prostate cancer: Asking men what's important. J Gen Intern Med 15:694-701, 2000
5. Fowler F, Collins M, Albertsen P, et al: Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283:3217-3222, 2000
6. Carvalhal G, Smith D, Ramos C, et al: Correlates of dissatisfaction with treatment in patients with prostate cancer diagnosed through screening. J Urol 162:113-118, 1999
7. Hoffman R, Hunt W, Gilliland F, et al: Patient satisfaction with treatment decisions for clinically localized prostate carcinoma: Results from the Prostate Cancer Outcomes Study. Cancer 97:1653-1662, 2003
8. Steginga S, Occhipinti S, Gardiner R, et al: Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer. Urology 63:751-756, 2004
9. Crawford ED, Bennett CL, Stone NN, et al: Comparison of perspectives on prostate cancer: Analyses of survey data. Urology 50:366-372, 1997
10. Hu J, Kwan L, Saigal C, et al: Regret in men treated for localized prostate cancer. J Urol 169:2279-2283, 2003
11. Clark J, Inui T, Silliman R, et al: Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 21:3777-3784, 2003
12. Talcott J, Rieker P, Clark J, et al: Patient-reported symptoms after therapy for early prostate cancer: Results of a prospective cohort study. J Clin Oncol 16:275-283, 1998
13. Talcott J, Manola J, Clark J, et al: Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 21:3979-3986, 2003
14. Clark J, Bokhour B, Inui T, Silliman R, Talcott J: Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Medical Care 41:923-936, 2003
15. Clark J, Talcott J: Symptom indexes to assess outcomes of treatment for early prostate cancer. Medical Care 39:1118-1130, 2001
16. Wei J, Dunn R, Litwin M, et al: Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899-905, 2000
17. Ware J, Kosinski M, Keller S: SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, 1994
18. Stewart A, Ware JEJ: Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press, 1992
19. McDonald L, Anderson H: Stigma in patients with rectal cancer: A community study. J Epidemiol Community Health 38:284-290, 1984
20. Talcott J, Clark J: Quality of life in prostate cancer. Eur J Cancer 41:922-931, 2005
21. Mehta S, Lubeck D, Pasta D, Litwin M: Fear of cancer recurrence in patients undergoing definitive treatment for prostate cancer: Results from CaPSURE. J Urol 170:1931-1933, 2003
22. Fowler F, Collins MM, Corkery E, et al: The impact of anodrogen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer 95:287-295, 2002
23. Lofters A, Juffs H, Pond G, et al: "PSA-itis": Knowledge of serum prostate specific antigen and other causes of anxiety in men with metastatic prostate cancer. J Urol 168:2516-2520, 2002
24. Hall J, Boyd J, Lippert M, et al: Why patients choose prostatectomy or brachytherapy for localized prostate cancer: Results of a descriptive survey. Urology 61:402-407, 2003
25. Davison BJ, Degner LF, Morgan TR: Information and decision-making preferences of men with prostate cancer. Oncol Nurs Forum 22:1401-1408, 1995
26. Steginga S, Occhipinti S: The application of the heuristic-systematic processing model to treatment decision making about prostate cancer. Med Decis Making 24:573-583, 2004